Structure Derivatization of IgG-Binding Peptides and Analysis of Their Secondary Structure by Circular Dichroism Spectroscopy.

affinity peptide antibody secondary structure structure–activity relationship

Journal

Chemical & pharmaceutical bulletin
ISSN: 1347-5223
Titre abrégé: Chem Pharm Bull (Tokyo)
Pays: Japan
ID NLM: 0377775

Informations de publication

Date de publication:
2024
Historique:
medline: 24 9 2024
pubmed: 24 9 2024
entrez: 23 9 2024
Statut: ppublish

Résumé

Mid-sized cyclic peptides are a promising modality for modern drug discovery. Their larger interaction area coupled with an appropriate secondary structure is more suitable than small molecules for binding to the target protein. In this study, we conducted a structure derivatization of an immunoglobulin G (IgG)-binding peptide (15-IgBP), a β-hairpin-like cyclic peptide with a twisted β-strand and assessed the effect of the secondary structure on IgG-binding activity using circular dichroism (CD) spectra analysis. As a result, derivatization at the Ala5 and Gly9 positions affected the secondary structure of 15-IgBP, in particular the appearance of a small positive peak in the 220-240 nm region characteristic of 15-IgBP in the CD spectrum. Maintaining this peak at a moderate level may be important for the expression of IgG binding activity. We found the small methyl group at Ala5 to be crucial for retaining the preferred secondary structure; we also found Gly9 could be replaced by D-amino acids. By integrating these findings with previous results of the structure-activity relationship, we obtained four potent affinity peptides for IgG binding (K

Identifiants

pubmed: 39313388
doi: 10.1248/cpb.c24-00430
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

831-837

Auteurs

Kyohei Muguruma (K)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Akane Fukuda (A)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Hayate Shida (H)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Akihiro Taguchi (A)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Kentaro Takayama (K)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Atsuhiko Taniguchi (A)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Yuji Ito (Y)

Department of Chemistry and Bioscience, Graduate School of Science and Engineering, Kagoshima University.

Yoshio Hayashi (Y)

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences.

Classifications MeSH